Experiment: 2LW1

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.6 mM [U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 0.111 mM DSS, 1 uM leupeptine, 1 uM pepstatine, 0.02 % sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O	200	7.2	1 atm	303
2	3D 1H-15N TOCSY	0.6 mM [U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 0.111 mM DSS, 1 uM leupeptine, 1 uM pepstatine, 0.02 % sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O	200	7.2	1 atm	303
3	2D 1H-15N HSQC	0.6 mM [U-100% 13C; U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 0.111 mM DSS, 1 uM leupeptine, 1 uM pepstatine A, 0.02 % sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O	200	7.2	1 atm	303
4	3D HNCO	0.6 mM [U-100% 13C; U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 0.111 mM DSS, 1 uM leupeptine, 1 uM pepstatine A, 0.02 % sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O	200	7.2	1 atm	303
5	3D HN(CA)CO	0.6 mM [U-100% 13C; U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 0.111 mM DSS, 1 uM leupeptine, 1 uM pepstatine A, 0.02 % sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O	200	7.2	1 atm	303
6	3D CBCA(CO)NH	0.6 mM [U-100% 13C; U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 0.111 mM DSS, 1 uM leupeptine, 1 uM pepstatine A, 0.02 % sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O	200	7.2	1 atm	303
7	3D HNCACB	0.6 mM [U-100% 13C; U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 0.111 mM DSS, 1 uM leupeptine, 1 uM pepstatine A, 0.02 % sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O	200	7.2	1 atm	303
8	3D HBHA(CO)NH	0.6 mM [U-100% 13C; U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 0.111 mM DSS, 1 uM leupeptine, 1 uM pepstatine A, 0.02 % sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O	200	7.2	1 atm	303
9	3D HCCH-TOCSY	0.6 mM [U-100% 13C; U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 1 uM leupeptine, 1 uM pepstatine A, 0.02 % sodium azide, 100 % D2O	100% D2O	200	7.2	1 atm	303
10	3D C(CO)NH	0.6 mM [U-100% 13C; U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 0.111 mM DSS, 1 uM leupeptine, 1 uM pepstatine A, 0.02 % sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O	200	7.2	1 atm	303
11	3D H(CCO)NH	0.6 mM [U-100% 13C; U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 0.111 mM DSS, 1 uM leupeptine, 1 uM pepstatine A, 0.02 % sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O	200	7.2	1 atm	303
12	2D 1H-13C HSQC	0.6 mM [U-100% 13C; U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 1 uM leupeptine, 1 uM pepstatine A, 0.02 % sodium azide, 100 % D2O	100% D2O	200	7.2	1 atm	303
13	3D 1H-15N NOESY	0.6 mM [U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 0.111 mM DSS, 1 uM leupeptine, 1 uM pepstatine, 0.02 % sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O	200	7.2	1 atm	303
14	3D 1H-13C NOESY aliphatic	0.6 mM [U-100% 13C; U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 1 uM leupeptine, 1 uM pepstatine A, 0.02 % sodium azide, 100 % D2O	100% D2O	200	7.2	1 atm	303
15	3D 1H-13C NOESY aromatic	0.6 mM [U-100% 13C; U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 1 uM leupeptine, 1 uM pepstatine A, 0.02 % sodium azide, 100 % D2O	100% D2O	200	7.2	1 atm	303
16	2D 1H-1H NOESY	0.6 mM [U-100% 15N] UUP, 170 mM sodium chloride, 30 mM TRIS, 0.111 mM DSS, 1 uM leupeptine, 1 uM pepstatine, 0.02 % sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O	200	7.2	1 atm	303

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	500
2	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
simulated annealing	CHARMM22 force field	NMRPipe

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	400
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	collection	Sparky		Goddard
3	chemical shift assignment	Sparky		Goddard
4	peak picking	Sparky		Goddard
5	geometry optimization	TopSpin	2.0	Bruker Biospin
6	structure solution	ARIA	2.2	Linge, O'Donoghue and Nilges
7	structure solution	CNS	1.1	Brunger, Adams, Clore, Gros, Nilges and Read
8	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.